ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,477.90
      0.16%
      US Tech 100
      19,124.40
      -0.26%
      Dow Jones
      39,127.80
      0.04%
      Brent Oil
      84.47
      0.34%
      Bitcoin
      60,783.70
      -1.66%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Cryptocurrencies
      4. COIN
      5. (Cryptocurrency:ADEGBP)

      6. (Cryptocurrency:ADEGBP) News

      ADEGBP

      (ADEGBP)

      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      2:09PMiHub NewswireFeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program
      06/26/20247:46PMPR Newswire (Canada)Government of Canada launches public consultation on artificial intelligence computing infrastructure
      06/26/20247:45PMGlobeNewswire Inc.Announcement Regarding Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange CommissionNYSE:MFGMizuho Financial Group Inc
      06/26/20247:45PMBusiness WirePatritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party ManufacturerNYSE:MRKMerck and Co Inc
      06/26/20247:45PMGlobeNewswire Inc.Announcement Regarding Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission8411.T
      06/26/20247:43PMBusiness WireTakeda kündigt neue Besetzung der Direktorenposten anNYSE:TAKTakeda Pharmaceutical Company Ltd
      06/26/20247:43PMBusiness WireTamboran Prices US IPO at US$24.00 Per ShareASX:TBNTamboran Resources Ltd
      06/26/20247:31PMBusiness WireCognite reconnue comme partenaire de l'année 2024 de Microsoft en matière d'énergie et de ressources
      06/26/20247:31PMBusiness WireCognite reconhecida como o Parceiro do Ano em Energia e Recursos da Microsoft em 2024
      06/26/20247:30PMBusiness WireChewy Announces $500 Million Repurchase of Shares from BC PartnersNYSE:CHWYChewy Inc
      06/26/20247:27PMPR Newswire (Canada)Laramide Resources Announces Voting Results from its Annual Meeting of ShareholdersTSX:LAMLaramide Resources Ltd
      06/26/20247:26PMPR Newswire (Canada)METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETINGTSXV:MTAMetalla Royalty and Streaming Ltd
      06/26/20247:26PMPR Newswire (US)METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETINGAMEX:MTAMetalla Royalty & Streaming Ltd
      06/26/20247:26PMPR Newswire (Canada)METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETINGAMEX:MTAMetalla Royalty & Streaming Ltd
      06/26/20247:25PMBusiness WireTakeda annonce de nouvelles nominations de directeursNYSE:TAKTakeda Pharmaceutical Company Ltd
      06/26/20247:23PMGlobeNewswire Inc.Else Nutrition Announces US$2 Million Offering of Units Priced At-The-MarketTSX:BABYElse Nutrition Holdings Inc
      06/26/20247:18PMGlobeNewswire Inc.NASP Applauds the Senate Finance Chairman for Working to Address Unfair PBM Practices
      06/26/20247:18PMBusiness WireArvest Bank and the Federal Home Loan Bank of Dallas Celebrate $15K Donation to Assist Affordable Housing Nonprofit
      06/26/20247:12PMPR Newswire (Canada)Revised - Medical Facilities Corporation Announces Second Quarter DividendTSX:DRMedical Facilities Corporation
      06/26/20247:08PMBusiness WireEPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)NASDAQ:GMABGenmab AS
      06/26/20247:08PMPR Newswire (US)Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
      06/26/20247:05PMPR Newswire (US)2bcloud Recognized as Winner of 2024 Microsoft Partner of the Year Award
      06/26/20247:05PMGlobeNewswire Inc.Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone4565.T
      06/26/20247:03PMPR Newswire (US)U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular LymphomaNYSE:ABBVAbbVie Inc
      06/26/20247:03PMGlobeNewswire Inc.EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)TG:GE9Genmab AS
      06/26/20247:01PMPR Newswire (US)Global IPO divergence widens as Americas and EMEIA surge and Asia-Pacific slows
      06/26/20247:01PMPR Newswire (US)Global IPO divergence widens as Americas and EMEIA surge and Asia-Pacific slows
      06/26/20247:01PMPR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le jeudi 27 juin 2024
      06/26/20247:00PMBusiness WireEnhance Your Garden Maintenance with the Yard Force LSC18-JP at Yard Force Japan
      06/26/20247:00PMGlobeNewswire Inc.PyroGenesis Provides Update Regarding Receipt of $4.1 Million Payment8PY